Symptom Monitoring and Health-Related Quality of Life in Non-metastatic Breast Cancer Patients: A Systematic Review

Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev. 2016;17:43–6. https://doi.org/10.7314/APJCP.2016.17.S3.43.

Article  PubMed  Google Scholar 

Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72:524–41. https://doi.org/10.3322/caac.21754.

Article  PubMed  Google Scholar 

Bottomley A, Reijneveld JC, Koller M, Flechtner H, Tomaszewski KA, Greimel E, et al. Current state of quality of life and patient-reported outcomes research. Eur J Cancer. 2019;121:55–63. https://doi.org/10.1016/j.ejca.2019.08.016.

Article  PubMed  Google Scholar 

Denieffe S, Gooney M. A meta-synthesis of women’s symptoms experience and breast cancer. Eur J Cancer Care (Engl). 2011;20:424–35. https://doi.org/10.1111/j.1365-2354.2010.01223.x.

Article  CAS  PubMed  Google Scholar 

Javan Biparva A, Raoofi S, Rafiei S, Pashazadeh Kan F, Kazerooni M, Bagheribayati F, et al. Global quality of life in breast cancer: systematic review and meta-analysis. BMJ Support Palliat Care. 2022;13:e528–36. https://doi.org/10.1136/bmjspcare-2022-003642.

Article  PubMed Central  Google Scholar 

Heins MJ, de Ligt KM, Verloop J, Siesling S, Korevaar JC, PSCCR group. Adverse health effects after breast cancer up to 14 years after diagnosis. Breast. 2022;61:22–8. https://doi.org/10.1016/j.breast.2021.12.001.

Article  PubMed  Google Scholar 

Dominick KL, Ahern FM, Gold CH, Heller DA. Relationship of health-related quality of life to health care utilization and mortality among older adults. Aging Clin Exp Res. 2002;14:499–508. https://doi.org/10.1007/BF03327351.

Article  PubMed  Google Scholar 

Warrington L, Absolom K, Conner M, Kellar I, Clayton B, Ayres M, et al. Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review. J Med Internet Res. 2019;21:e10875. https://doi.org/10.2196/10875.

Article  PubMed  PubMed Central  Google Scholar 

Lizán L, Pérez-Carbonell L, Comellas M. Additional value of patient-reported symptom monitoring in cancer care: a systematic review of the literature. Cancers (Basel). 2021;13:4615. https://doi.org/10.3390/cancers13184615.

Article  PubMed  PubMed Central  Google Scholar 

Consolo L, Castellini G, Cilluffo S, Basile I, Lusignani M. Electronic patient-reported outcomes (e-PROMs) in palliative cancer care: a scoping review. J Patient-Reported Outcomes. 2022;6:102.

Article  Google Scholar 

Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA. 2022;327:2413–22.

Article  PubMed  PubMed Central  Google Scholar 

van den Hurk CJG, Mols F, Eicher M, Chan RJ, Becker A, Geleijnse G, et al. A narrative review on the collection and use of electronic patient-reported outcomes in cancer survivorship care with emphasis on symptom monitoring. Curr Oncol. 2022;29:4370–85.

Article  PubMed  PubMed Central  Google Scholar 

Maguire R, McCann L, Kotronoulas G, Kearney N, Ream E, Armes J, et al. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ. 2021; n1647. https://doi.org/10.1136/bmj.n1647

Howell D, Li M, Sutradhar R, Gu S, Iqbal J, O’Brien MA, et al. Integration of patient-reported outcomes (PROs) for personalized symptom management in “real-world” oncology practices: a population-based cohort comparison study of impact on healthcare utilization. Support Care Cancer. 2020;28:4933–42.

Article  PubMed  Google Scholar 

Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34:557–65.

Article  CAS  PubMed  Google Scholar 

Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, et al. Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients. J Natl Cancer Inst. 2017; 109. [Internet], Available from: http://www.ncbi.nlm.nih.gov/pubmed/28423407

Basch E, Stover AM, Schrag D, Chung A, Jansen J, Henson S, et al. Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial. JCO Clin cancer informatics. 2020;4:947–57.

Article  Google Scholar 

Lee M, Kang D, Kang E, Kim S, Kim Y, Ahn JS, et al. Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial. Support Care Cancer. 2023;31:321. https://doi.org/10.1007/s00520-023-07779-3.

Article  PubMed  PubMed Central  Google Scholar 

Billingy NE, Tromp VNMF, Aaronson NK, Hoek RJA, Bogaard HJ, Onwuteaka-Philipsen BD, et al. Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial. JNCI J Natl Cancer Inst. 2023;15:1515–25. https://doi.org/10.1093/jnci/djad159/7246746.

Article  Google Scholar 

van Eenbergen MC, van den Hurk C, Mols F, van de Poll-Franse LV. Usability of an online application for reporting the burden of side effects in cancer patients. Support Care Cancer. 2019;27:3411–9. https://doi.org/10.1007/s00520-019-4639-1.

Article  PubMed  Google Scholar 

Graupner C, Kimman ML, Mul S, Slok AHM, Claessens D, Kleijnen J, et al. Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review. Support Care Cancer. 2021;29:573–93. https://doi.org/10.1007/s00520-020-05695-4.

Article  PubMed  Google Scholar 

Finucane AM, O’Donnell H, Lugton J, Gibson-Watt T, Swenson C, Pagliari C. Digital health interventions in palliative care: a systematic meta-review. npj Digit Med. 2021;4:64.

Article  PubMed  PubMed Central  Google Scholar 

Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008;16:791–801.

Article  PubMed  Google Scholar 

Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis. Cancer Epidemiol. 2017;48:140–6.

Article  PubMed  PubMed Central  Google Scholar 

Federatie Medisch Specialisten. borstkanker richtlijnen. 2022; Available from: https://richtlijnendatabase.nl/richtlijn/borstkanker/algemeen.html. Accessed 25 Oct 2022

Solvi AS, Foss K, von Soest T, Roald HE, Skolleborg KC, Holte A. Motivational factors and psychological processes in cosmetic breast augmentation surgery. J Plast Reconstr Aesthetic Surg. 2010;63:673–80.

Article  Google Scholar 

Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288–300.

Article  CAS  PubMed  Google Scholar 

Clarijs ME, Thurell J, Kühn F, Uyl-de Groot CA, Hedayati E, Karsten MM, et al. Measuring quality of life using patient-reported outcomes in real-world metastatic breast cancer patients: the need for a standardized approach. Cancers (Basel). 2021;13:2308.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71.

Article  Google Scholar 

Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928–d5928. https://doi.org/10.1136/bmj.d5928.

Article  PubMed  PubMed Central  Google Scholar 

Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 29 Mar 2023

Öztürk ES, Kutlutürkan S. The effect of the mobile application-based symptom monitoring process on the symptom control and quality of life in breast cancer patients. Semin Oncol Nurs. 2021;37:151161.

Article  PubMed  Google Scholar 

Takada F, Okuyama H, Nakamura S, Fujita K. Application of personal health record in enhancing the quality of life in patients with breast cancer who received adjuvant hormonal therapy. Eur J Breast Heal. 2022;18:155–62.

Article  Google Scholar 

Fjell M, Langius-Eklöf A, Nilsson M, Wengström Y, Sundberg K. Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer – A randomized controlled trial. The Breast. 2020;51:85–93.

Article  PubMed  PubMed Central  Google Scholar 

Grašič Kuhar C, Gortnar Cepeda T, Kovač T, Kukar M, Ružić Gorenjec N. Mobile app for symptom management and associated quality of life during system

Comments (0)

No login
gif